Enviaments recents

Consensus on early detection of disease progression in patients with multiple sclerosis

Casanova, Bonaventura; Rodríguez-Antigüedad, Alfredo; Eichau-Madueño, Sara; Izquierdo, Guillermo; Durán, Carmen; Rio Izquierdo, Jordi; Meca-Lallana, Jose Eustasio (Data de publicació: 2022-11-03)

Consensus; Early detection; Secondary progressive multiple sclerosis

Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis

Montalban Gairín, Xavier; Solari, Alessandra; Brochet, Bruno; Langdon, Dawn; Piehl, Fredrik; Lechner-Scott, Jeannette; Hupperts, Raymond (Data de publicació: 2022-07-19)

Cladribine tablets; Relapsing multiple sclerosis; Treatment satisfaction

Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis

Ciccarelli, Olga; Calabrese, Massimiliano; De Stefano, Nicola; Eshaghi, Arman; Filippi, Massimo; Barkhof, Frederik; Rovira, Alex; Sastre Garriga, Jaume; TUR, CARMEN (Data de publicació: 2024-06-26)

Relapse; Pathobiological foundations; Multiple sclerosis

Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis

Zanga, Gisela Mariel; Drzewiscki, Estefania; Tagliani, Paula; Smietniansky, Maximiliano; Esnaola Rojas, Maria M.; Caruso, Diego (Data de publicació: 2022-06-20)

Disease-modifying therapies; Multiple sclerosis; Predictors

Deciphering Multiple Sclerosis Progression

Berenguer-Ruiz, Leticia; Carreres-Polo, Joan; Eichau-Madueño, Sara; Ferrer-Lozano, Jaime; Forero, Lucía; Vidal Jordana, Angela; Meca-Lallana, Virginia (Data de publicació: 2021-12-23)

Esclerosi múltiple; Neurodegeneració

Women's Health in Multiple Sclerosis: A Scoping Review

Ng, Huah Shin; O’Mahony, Julia; Cohen, Jeffrey A; Harnegie, Mary Pat; Tintore Subirana, Mar; Amato, Maria Pia; Ross, Lindsay (Data de publicació: 2022-07-20)

Multiple sclerosis; Pregnancy; Women's health

Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis

Carrión, Belinda; Liu, Yawei; Hadi, Mahdieh; Lundstrom, Jon; Christensen, Jeppe Romme; Ammitzbøll, Cecilie; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Data de publicació: 2022-04-22)

Progressive Multiple Sclerosis; T Cells

Impact of the COVID-19 pandemic on the physical activity habits of people with multiple sclerosis in Spain

Santoyo-Medina, Carme; Elorriaga Mínguez, Iratxe; Loyola Sanmillán, Gaizka; YEREGUI PRIETO, IZASKUN; Berriozabalgoitia Etxaniz, Rakel; Janer i Cabo, Montserrat; SANCHEZ POUS, SAMUEL; Meza Murillo, Edwin Roger; Galan, Ingrid (Data de publicació: 2024-04-16)

Multiple sclerosis; Physical activity; COVID-19 pandemic

Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study

Oreja-Guevara, Celia; MECA-LALLANA, JOSE EUSTASIO; Diaz, Judit; Ara Callizo, José Ramón; Hernández Perez, Miguel Angel; Gracia Gil, Julia; Rio, Jordi (Data de publicació: 2024-10-18)

Cognitive impairment; Indirect costs; Secondary progressive multiple sclerosis

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions

Cohen, Jeffrey A; Grossman, Cynthia; Hersh, Carrie; Hyland, Megan; Mowry, Ellen; Tintore Subirana, Mar; Zabalza de Torres, Ana; Montalban Gairín, Xavier; Bermel, Robert (Data de publicació: 2022-09-07)

Multiple sclerosis; SARS-COV-2 vaccination; Humoral immune response

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

Saposnik, Gustavo; Mamdani, Muhammad; Montalban Gairín, Xavier; Terzaghi, Maria A; Silva, Berenice; Saladino, Maria Laura (Data de publicació: 2019-07-19)

Decision making; Disease-modifying therapy; Multiple sclerosis

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study

Balk, Lisanne J; Coric, Danko; Knier, Benjamin; Zimmermann, Hanna G; Behbehani, Raed; Alroughani, Raed; Vidal Jordana, Angela; Montalban Gairín, Xavier (Data de publicació: 2020-07-02)

Inner nuclear layer; Multiple sclerosis; Optical coherence tomography

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

Montalban Gairín, Xavier; Alvarez, Enrique; Davydovskaya, Maria; Delgado, Silvia R; Bar-Or, Amit; Wiendl, Heinz (Data de publicació: 2022-07-19)

Ofatumumab; Multiple sclerosis; Pharmacokinetics

The ageing central nervous system in multiple sclerosis: the imaging perspective

Preziosa, Paolo; Cossarizza, Andrea; Filippi, Massimo; Barkhof, Frederik; Ciccarelli, Olga; De Stefano, Nicola; Rovira, Alex; Sastre Garriga, Jaume (Data de publicació: 2025-01-08)

Magnetic resonance imaging; Ageing; Multiple sclerosis

The potential of serum neurofilament as biomarker for multiple sclerosis

Bittner, Stefan; Tintore Subirana, Mar; Zipp, Frauke; Oh, Jiwon; Kubala Havrdova, Eva (Data de publicació: 2022-06-07)

Biomarcadores; Neurofilamento; Respuesta a la terapia

Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial

Montalban Gairín, Xavier; Hu, Xixi; Kropshofer, Harald; Kukkaro, Petra; Coello, Neva; Bar-Or, Amit (Data de publicació: 2023-02-17)

Biomarker; Ofatumumab; Relapsing multiple sclerosis

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis

Hauser, Stephen L.; Montalban Gairín, Xavier; Craveiro, Licinio; Chognot, Cathy; Hughes, Richard; Kappos, Ludwig (Data de publicació: 2022-07-18)

Multiple sclerosis; Patient safety; Medical care

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

Fernández-Prada, María; Garcia Vázquez, Elisa; Moreno Guillén, S.; Otero Romero, Susana; Rus-Hidalgo, Macarena; Montalban Gairín, Xavier; Meca-Lallana, Jose Eustasio (Data de publicació: 2022-11-16)

Alemtuzumab; Eficacia; Práctica clínica habitual

Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI

Coll Benejam, Llucia; Pareto Onghena, Deborah; Carbonell i Mirabent, Pere; Cobo Calvo, Alvaro; Arrambide, Georgina; Vidal Jordana, Angela; Castillo Justribo, Joaquin; Zabalza de Torres, Ana; Galán Cartaña, Ingrid; Midaglia Fernandez, Luciana; Nos Llopis, Carlos; Salerno, Anna Laura; Auger Acosta, Cristina; Alberich Jordà, Manel; Rio Izquierdo, Jordi; Oliver, Arnau; Montalban Gairín, Xavier; Rovira Cañellas, Alex; Tintore Subirana, Mar; Tur Gomez, Carmen; Sastre Garriga, Jaume; Comabella Lopez, Manuel; Rodriguez Acevedo, Breogan; Llado, Xavier (Data de publicació: 2023-03-29)

Deep learning; Disability; Structural MRI

The OSCAR-MP Consensus Criteria for Quality Assessment of Retinal Optical Coherence Tomography Angiography

Wicklein, Rebecca; Yam, Charmaine; Noll, Christina; Aly, Lilian; Banze, Nicolas; Romahn, Eva Feodora; Cabello, Sergio; Vidal-Jordana, Angela (Data de publicació: 2023-10-18)

Consensus; Angiography; Retina

Centre d'Esclerosi Múltiple de Catalunya – CEMCAT: Enviaments recents

Consensus on early detection of disease progression in patients with multiple sclerosis ﻿

Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis ﻿

Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis ﻿

Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis ﻿

Deciphering Multiple Sclerosis Progression ﻿

Women's Health in Multiple Sclerosis: A Scoping Review ﻿

Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis ﻿

Impact of the COVID-19 pandemic on the physical activity habits of people with multiple sclerosis in Spain ﻿

Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study ﻿

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions ﻿

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care ﻿

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study ﻿

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study ﻿

The ageing central nervous system in multiple sclerosis: the imaging perspective ﻿

The potential of serum neurofilament as biomarker for multiple sclerosis ﻿

Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial ﻿

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis ﻿

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain ﻿

Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI ﻿

The OSCAR-MP Consensus Criteria for Quality Assessment of Retinal Optical Coherence Tomography Angiography ﻿